Impfstoffe aus Lipidnanopartikel-Mrna

Details

Veröffentlichungs-Nr.

EP4768468

Anmeldetag

26. Oktober 2017

Veröffentlichung

1. Juli 2026

Rechtsraum

EP

IPC

C07C255/24

Abstract

The invention relates to mRNA comprising lipid nanoparticles and their medical uses. The lipid nanoparticles of the present invention comprise a cationic lipid according to formula (I), (II) or (III) and/or a PEG lipid according to formula (IV), as well as an mRNA compound comprising an mRNA sequence encoding an antigenic peptide or protein. The invention further relates to the use of said lipid nanoparticles as vaccines or medicaments, in particular with respect to influenza or rabies vaccination.

Anmelder

Firmen

CureVac SE
Acuitas Therapeutics Inc.

Land

🇩🇪 Deutschland